Orange juice as dietary source of antioxidants for patients with hepatitis C under antiviral therapy

Food and Nutrition Research

Volumn 61, Issue 1, 2017, Pages

  Gonçalves, Danielle ^a   Lima, Claudia ^a   Ferreira, Paula ^a   Costa, Paulo ^a   Costa, Angela ^b   Figueiredo, Walter ^b   Cesar, Thais ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidants; Biochemical markers; Chronic hepatitis C; Nutritional status; Orange juice; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRACE ELEMENT;

ANTIVIRAL THERAPY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS C; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY CONSUMPTION; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MACRONUTRIENT; MALE; NUTRITIONAL STATUS; ORANGE JUICE; PARALLEL DESIGN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE;

EID: 85034587329     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.1080/16546628.2017.1296675     Document Type: Article

References (57)

1. Rosen HR. Chronic hepatitis C infection. N Engl J Med. 2011;77:2429–2438.
2. El-Zayadi A-R, Anis M. Hepatitis C virus induced insulin resistance impairs response to antiviral therapy. World J Gastroenterol. 2012;18:212–224. DOI:10.3748/wjg.v18.i3.212
3. Huang CF, Hsieh MY, Yang JF, et al. Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients. Hepatol Int. 2010;4:621–627. DOI:10.1007/s12072-010-9200-8
4. Bartenschlager R, Cosset F-L, Lohmann V. Hepatitis C virus replication cycle. J Hepatol. 2010;53:583–585.
5. Petit JM, Minello A, Duvillard L, et al. Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load. Am J Physiol Endocrinol Metab. 2007;293:E416–E420. DOI:10.1152/ajpendo.00091.2007
6. Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87. DOI:10.1002/hep.27259
7. Lin CC, Yin MC. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. Clin Nutr. 2009;28:34–38. DOI:10.1016/j.clnu.2008.09.003
8. Franke AA, Cooney RV, Henning SM, et al. Bioavailability and antioxidant effects of orange juice components in humans. J Agric Food Chem. 2005;53:5170–5178. DOI:10.1021/jf050054y
9. Bhagwat S, Haytowitz DB, Holden JM U.S. department of agriculture database for the flavonoid content of selected foods. USDA. 2013 Dec [cited 2014 Mar 04]. Release 3.1: [about p. 37]. Available from: https://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/Flav/Flav3-1.pdf
10. Sánchez-Moreno C, Cano MP, Ancos B, et al. Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans. Am J Clin Nutr. 2003;78:454–460.
11. Wilcox LJ, Borradaile NM, Dreu LE, et al. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. Lipid Res. 2001;42:725–734.
12. Nahmias Y, Goldwasser J, Casali M, et al. Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology. 2008;47:1437–1445. DOI:10.1002/hep.22197
13. Murakami Y, Koyabu T, Kawashima A, et al. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during therapy with pegylated interferon α-2b and ribavirin. J Nutr Sci Vitaminol. 2007;53:213–218.
14. Farias MS, Budni P, Ribeiro CM, et al. Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. Gastroenterol Hepatol. 2012;35:386–394. DOI:10.1016/j.gastrohep.2012.03.004
15. Ministry of Health of Brazil. Protocolo Clínico e Diretrizes Terapêuticas para Hepatite Viral C e Coinfecções. 2011 Jul. [cited 2012 Aug 23]. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/protocolos_diretrizes_hepatite_viral_c_coinfeccoes.pdf
16. Siri WE. Body composition from fluid spaces and density. Analysis of methods. In: Brozek J, Henschel A, editors. Techniques for measuring body composition. Washington (DC): National Academy of Sciences, National Research Council; 1961. p. 223–224.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;23:412–419.
19. Janaszewska A, Bartosz G. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest. 2002;62:231–236.
20. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998;108:101–106.
21. Nasser ALM, Dourado GKZS, Manjate DA, et al. Oxidative stress evaluation on the blood of regular consumers of orange juice. Rev Ciênc Farm Basica Apl. 2011;32:275–279.
22. Huisman EJ, van Hoek B, van Soest H, et al. Preventive versus “on-demand” nutritional support during antiviral treatment for hepatitis C: a randomized controlled trial. J Hepatol. 2012;57:1069–1075. DOI:10.1016/j.jhep.2012.06.029
23. Panchal SK, Poudyal H, Iyer A, et al. High carbohydratehigh fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57:611–624. DOI:10.1097/FJC.0b013e31821b1379
24. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology. 1999;29:1215–1219.
25. Siren R, Eriksson JG, Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease. BMC Public Health. 2012;12:631. DOI:10.1186/1471-2458-12-631
26. National Academy of Sciences. DRI (Dietary Reference Intakes) for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). 2009. [cited 2013 Feb 28]. Available from: http://www.nap.edu/
27. Murakami Y, Nagai A, Kawakami T, et al. Vitamin E and Csupplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin. Nutrition. 2006;22:114–122. DOI:10.1016/j.nut.2005.05.014
28. Vitaglione P, Fogliano V, Stingo S, et al. Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. Eur J Clin Nutr. 2007;61:906–915. DOI:10.1038/sj.ejcn.1602571
29. Nashaat EH. Lipid profile among chronic hepatitis C Egyptian patients and its levels pre and post treatment. Nat Sci. 2010;8:83–89.
30. Corey KE, Kane E, Munroe C, et al. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology. 2009;50:1030–1037. DOI:10.1002/hep.23219
31. Fujino T, Nakamuta M, Yada R, et al. Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res. 2010;40:923–929. DOI:10.1111/j.1872-034X.2010.00700.x
32. Yang W, Hood BL, Chadwick SL, et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology. 2008;48:1396–1403. DOI:10.1002/hep.22508
33. Andrus MR, East J. Use of statins in patients with chronic hepatitis C. South Med J. 2010;103:1018–1022. DOI:10.1097/SMJ.0b013e3181f0c6b4
34. Butt AA, Yan P, Bonilla H, et al. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: results from ERCHIVES. Hepatology. 2015;62:365–374.
35. Chandra R, Dolder NM, Dolder CR, et al. Treatment of dyslipidemia with statins by primary care providers in Veterans with and without chronic Hepatitis C. Am J Health Syst Pharm. 2016;73:S30–S34. DOI:10.2146/sp150030
36. Mullen W, Archeveque M-A, Edwards CA, et al. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem. 2008;56:11157–11164. DOI:10.1021/jf801974v
37. Silveira JQ, Cesar TB, Manthey JA, et al. Pharmacokinetics of flavanone glycosides after ingestion of single doses of fresh-squeezed orange juice versus commercially processed orange juice in healthy humans. J Agric Food Chem. 2014;62:12576–12584. DOI:10.1021/jf5038163
38. Kanaze FI, Bounartzi MI, Georgarakis M, et al. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007;61:472–477.
39. Kim HK, Jeong TS, Lee MK, et al. Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta. 2003;327:129–137.
40. Aptekmann NP, Cesar TB. Long-term orange juice consumption is associated with low LDL-cholesterol and apolipoprotein B in normal and moderately hypercholesterolemic subjects. Lipids Health Dis. 2013;12:1–10. DOI:10.1186/1476-511X-12-119
41. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533–537.
42. Jain SK, Pemberton PW, Smith A, et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol. 2002;36:805–811.
43. Chan SW. Establishment of chronic hepatitis C virus infection. Translational evasion of oxidative defense. World J Gastroenterol. 2014;20:2785–2800. DOI:10.3748/wjg.v20.i11.2785
44. Paracha UZ, Fatima K, Alqahtani M, et al. Oxidative stress and hepatitis C virus. Virol J. 2013;10:251. DOI:10.1186/1743-422X-10-251
45. Bandara P, George J, McCaughan G, et al. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C. Liver Int. 2005;25:518–526. DOI:10.1111/j.1478-3231.2005.01049.x
46. Haidari F, Keshavarz SA, Rashidi MR, et al. Orange juice and hesperidin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity. J Clin Biochem Nutr. 2009;45:285–291. DOI:10.3164/jcbn.09-15
47. Tirkey N, Pilkhwal S, Kuhad A, et al. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacology. 2005;5:2. DOI:10.1186/1471-2210-5-2
48. Mendiratta S, Qu ZC, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med. 1998;24:789–797.
49. Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22:18–35.
50. Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015;5:27986–28006.
51. May JM. Ascorbate function and metabolism in the human erythrocyte. Front Biosci. 1998;3:d1–d10.
52. Ji HF, Sun Y, Shen L. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta- analysis. Nutrition. 2014;30:986–991. DOI:10.1016/j.nut.2014.01.016
53. Kaur G, Tirkey N, Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology. 2006;226:152–160. DOI:10.1016/j.tox.2006.06.018
54. Renugadevi J, Prabu SM. Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol. 2010;62:171–181. DOI:10.1016/j.etp.2009.03.010
55. Prabu SM, Shagirtha K, Renugadevi J. Naringenin in combination with vitamins C and E potentially protects oxidative stress-mediated hepatic injury in cadmium-intoxicated rats. J Nutr Sci Vitaminol. 2011;57:177–185.
56. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487–48490.
57. Devaraj S, Autret BC, Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr. 2006;84:756–761.